Urolithin A and Mitopure®: What Human Clinical Trials Really Show About Muscle, Mitochondria, and Healthy Aging
- Jaime Hernandez
- 19 hours ago
- 8 min read
Urolithin A and Mitopure®: What Human Clinical Trials Really Show About Muscle, Mitochondria, and Healthy Aging
A Science-Based Health and Exercise Prescriptions® Guide to Mitophagy, Strength, Endurance, and Immune Aging
Longevity supplements often arrive with dramatic promises. They claim to reverse aging, rebuild cellular energy, rejuvenate the immune system, or reproduce the effects of exercise in a capsule.
Urolithin A deserves a more thoughtful conversation.
Unlike many trending longevity compounds supported primarily by animal experiments, urolithin A has been evaluated in several randomized, double-blind, placebo-controlled human trials. The research suggests that it may support selected measures of muscle strength, muscular endurance, mitochondrial metabolism, and immune-cell function.
But the evidence does not show that urolithin A reverses aging, extends human lifespan, or replaces exercise.
At Health and Exercise Prescriptions®, that distinction matters. Supplements should strengthen a well-built health plan—not become substitutes for movement, sleep, nutrition, recovery, or appropriate medical care.
What Are Urolithin A and Mitopure®?
Urolithin A is a postbiotic compound. It can be produced when certain intestinal bacteria metabolize ellagitannins and ellagic acid found in foods such as pomegranates, walnuts, raspberries, and some other berries.
However, people differ considerably in their ability to produce meaningful amounts of urolithin A from food. Gut-microbiome composition appears to be one reason for this variation. Direct supplementation was developed to provide a more predictable amount without depending entirely on an individual’s microbial conversion capacity.
Mitopure® is not the name of the biological compound itself. It is a proprietary, commercially produced form of urolithin A used in several clinical trials.
That distinction is important when reading research or comparing products. A study performed with Mitopure® does not automatically prove that every supplement labeled “urolithin A” has identical purity, stability, dosing, or bioavailability.
Why Mitochondrial Quality Matters as We Age
Mitochondria help cells convert oxygen and nutrients into usable energy. Muscle cells have especially high energy demands, which makes healthy mitochondrial function important for strength, endurance, recovery, and daily mobility.
Mitochondria are not permanent structures. They can become damaged and less efficient. The body uses a quality-control process called mitophagy to identify, dismantle, and recycle dysfunctional mitochondria.
Think of mitophagy as cellular maintenance. Instead of allowing damaged energy-producing structures to accumulate, the cell clears some of them so that a healthier mitochondrial network can be maintained.
Age-related changes in mitochondrial quality control are one reason urolithin A has attracted scientific attention. Early human research found that supplementation was well tolerated and produced molecular changes associated with mitochondrial and cellular health, although biomarkers are not the same as confirmed improvements in long-term health or lifespan.
The Middle-Aged Adult Trial: Strength Improved, but the Primary Endpoint Did Not
A 2022 randomized, placebo-controlled trial published in Cell Reports Medicine studied urolithin A supplementation for four months in middle-aged adults. Participants received either a placebo or one of two daily urolithin A doses.
The most publicized result was an approximately 12% improvement in certain hamstring strength measurements. The higher-dose group also showed potentially meaningful changes in peak oxygen consumption and six-minute walking performance. Muscle biopsies demonstrated increased expression of proteins connected with mitochondrial metabolism and mitophagy. Researchers also reported reductions in plasma acylcarnitines and C-reactive protein.
Those findings are encouraging, but they require context.
The study’s primary endpoint—peak power output—did not improve significantly. That means it would be inaccurate to summarize the trial simply by saying that urolithin A conclusively improved overall physical performance.
A more responsible interpretation is that four months of supplementation improved selected strength measurements, exercise-performance measures, and mitochondrial biomarkers, while failing to significantly improve the trial’s primary performance outcome.
That is still valuable evidence. It is simply not the same as proof of comprehensive physical rejuvenation.
The Older-Adult Trial: Better Fatigue Resistance, but No Significant Primary-Endpoint Improvement
Another 2022 randomized clinical trial, published in JAMA Network Open, studied adults between 65 and 90 years of age. Participants received 1,000 milligrams of urolithin A or a placebo daily for four months.
Urolithin A was generally safe and well tolerated. The researchers found improvements in selected measures of hand and leg muscular endurance, meaning the muscles demonstrated greater resistance to fatigue during repeated contractions. Biomarkers associated with mitochondrial metabolism also changed in a favorable direction.
However, the trial did not demonstrate significant improvements in its primary endpoints: six-minute walking distance and maximal ATP production in hand muscle.
The practical takeaway is not that the trial failed. It showed that urolithin A may influence local muscular endurance and mitochondrial biology even when larger whole-body outcomes do not change significantly.
For older adults, fatigue resistance could be relevant to climbing stairs, carrying groceries, standing for longer periods, gardening, or maintaining daily activity. Larger and longer independent trials are still needed to determine whether these laboratory and performance changes consistently translate into better independence, fewer falls, reduced disability, or improved quality of life.
The Emerging Athletic Evidence
A small 2024 randomized, double-blind, placebo-controlled study examined 20 resistance-trained male athletes. After eight weeks at 1,000 milligrams per day, the urolithin A group showed improvements in selected measures of muscle strength and endurance, along with changes in inflammatory and oxidative-stress measurements.
This study expands the conversation beyond sedentary or older populations, but it should be interpreted cautiously. Twenty participants are not enough to establish universal athletic-performance recommendations, and findings in trained young men may not apply to women, post-rehabilitation clients, older adults, or people with chronic medical conditions.
Urolithin A remains an emerging sports-nutrition compound—not a proven replacement for properly designed strength, cardiovascular, recovery, or nutrition programs.
The 2025 Immune-Aging Trial
The most recent major human trial was published in Nature Aging on October 31, 2025.
In this randomized, double-blind, placebo-controlled study, 50 healthy adults between 45 and 70 years old received either 1,000 milligrams of urolithin A or placebo daily for 28 days.
The study found changes in CD8-positive immune-cell populations, including an increase in cells with a more naïve-like and less terminally exhausted profile. Researchers also observed increased fatty-acid oxidation capacity in CD8-positive cells, greater mitochondrial biogenesis, and changes in several other immune-cell populations and functional measurements.
The findings support the idea that mitochondrial quality control can influence immune-cell metabolism and composition.
However, saying that the supplement “rejuvenated the immune system” may lead readers to believe that participants became less likely to develop infections, cancer, or other age-related diseases. The four-week study was not designed to establish those outcomes.
It demonstrated short-term biological remodeling of immune cells—not proven disease prevention or extended longevity.
What the Research Supports—and What It Does Not
Based on the current human evidence, urolithin A may support:
Selected measures of muscular strength
Resistance to muscular fatigue
Mitochondrial metabolic biomarkers
Proteins associated with mitophagy
Selected exercise-capacity measurements
Short-term immune-cell metabolic remodeling
Current research does not establish that urolithin A:
Reverses biological aging
Extends human lifespan
Prevents infections or cancer
Treats sarcopenia by itself
Replaces resistance or cardiovascular exercise
Produces identical results in every population
Has fully established long-term safety across many years
Another important consideration is that several influential trials were funded by, supplied by, or included researchers affiliated with the company that developed Mitopure®. That does not invalidate the research, but it makes independent replication especially important. The 2025 Nature Aging paper openly reported relevant company employment, funding, consulting, and product-supply relationships.
The HEP® Practical Prescription
I view urolithin A as a possible supporting tool—not the foundation of healthy aging.
The strongest mitochondrial prescription available to most people is still appropriately dosed movement. Strength training challenges muscle to maintain force. Cardiovascular exercise challenges the body to transport and use oxygen. Walking supports daily energy expenditure and circulation. Protein supplies building material. Sleep and recovery allow adaptation to take place.
A complete healthy-aging structure may include:
Progressive strength training two or three times per week
Regular walking and appropriate cardiovascular conditioning
Balance and mobility practice
Adequate protein and total nutrition
Consistent sleep and recovery rhythms
Stress regulation and restorative practices
Medical management of relevant health conditions
Carefully selected supplements when appropriate
For post-rehabilitation clients, the prescription must also account for pain, surgical history, joint tolerance, cardiovascular status, medications, movement confidence, and current functional capacity.
A supplement cannot perform those assessments for you.
Food First—or Direct Supplementation?
Pomegranates, walnuts, and berries remain valuable foods even when someone does not efficiently produce urolithin A. They provide fiber, polyphenols, vitamins, minerals, and other compounds that support health through multiple pathways.
Direct urolithin A supplementation offers a more standardized exposure, but it should not become an excuse to neglect dietary diversity or gut health.
For a practical gut-forward meal, read:
To understand why exercise remains the central healthy-aging signal, read:
For a whole-body approach connecting movement, recovery, sleep, nutrition, and nervous-system health, read:
The Bottom Line
Urolithin A is one of the more scientifically credible compounds in the modern longevity-supplement conversation.
Human trials suggest possible benefits for selected measures of muscle strength, fatigue resistance, mitochondrial biology, and immune-cell metabolism. The results are promising enough to justify continued investigation.
They are not strong enough to call urolithin A an anti-aging cure.
For a person trying to recover after rehabilitation, stay active after 50, maintain independence, or preserve the ability to hike, golf, travel, carry groceries, and play with grandchildren, the priorities remain clear:
Train safely. Build strength. Protect your sleep. Eat enough protein. Support the microbiome. Recover deliberately. Use supplements selectively and with professional guidance.
Your body does not need another miracle promise.
It needs a complete prescription.
Build Your Personal Health Prescription
Learn more about personalized medical exercise, post-rehabilitation support, therapeutic bodywork, and functional wellness:
Explore professional-quality foundational supplement support:
Read client experiences:
Scientific References
Andreux PA, et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. 2019. PubMed
Singh A, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. 2022. PubMed
Liu S, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. 2022. Full study
Zhao H, et al. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training. 2024. PubMed
Denk D, et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nature Aging. 2025. Full study
Legal and Medical Disclaimer
This content is for educational purposes only and does not constitute medical or rehabilitation advice. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Consult your physician or qualified healthcare provider before starting or changing an exercise, dietary, or supplement program—especially if you have pain, injuries, cardiovascular disease, metabolic conditions, kidney or liver concerns, immune disorders, take prescription medications, are pregnant or breastfeeding, or are preparing for surgery.
Stop any activity that causes sharp pain, dizziness, chest discomfort, faintness, unusual shortness of breath, or other concerning symptoms.
Author Bio
Jaime Hernandez is a certified health and wellness professional with 25 years expertise in medical exercise, personal training, therapeutic bodywork, massage, and holistic fitness. He is the founder and Executive Coach of Health and Exercise Prescriptions® in Bellingham, WA, where he develops personalized health and wellness plans designed to help individuals improve strength, mobility, and overall well-being across all stages of life.
Jaime holds certifications as a Medical Exercise Specialist, Licensed Massage Therapist # MA60804408, and trainer in Yoga, Pilates, and Craniosacral Therapy, combining multiple modalities to support post-rehabilitation recovery, preventive health, and functional movement optimization. His approach blends science-based exercise prescription with therapeutic practice to help clients prevent disease, manage chronic conditions, and achieve their health goals.
Health and Exercise Prescriptions®
Thank you for your time and energy...Be well.
Comments